Sectors > > Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc(TSX:AUP)

Market Overview

8.19

0.13(1.56%)
Vol 35,455
10 Days Avg Vol 7600
3 Mo Avg Vol 11800
52 Wk Lo/Hi $2.75 - $7.0
YTD Price Gain % 7.5%
10 Wks Moving Avg 4.91
200 Days Moving Avg 4.44
Liquidity Ratio 11.0
Market Cap 142,996,520

Related News View All

Summary

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.

Contact Information


Aurinia Pharmaceuticals Inc

Suite 1203
4464 Markham Street

Victoria BC V8Z 7X8

(250) 708-4272

(250) 744-2498

www.auriniapharma.com

Stephen W. Zaruby